CORRELATION BETWEEN OBESITY AND TESTOSTERONE LEVEL, ANXIETY SYMPTOMS, DEPRESSION AND ACCELERATED AGING IN MEN

Author: Vasileva O.V.¹, Selyatitskaya V.G.²

Abstract

The aim of the investigation was to study the relationship of blood testosterone levels with the severity of anxiety signs, depression and urological pathology symptoms in men of mature age with normal weight, overweight and obesity. Material and methods: 188 men of 36.7 average age participated in the study. Anthropometric examination was carried out, the HADS questionnaire (Hospital Anxiety and Depression Scale, 1983) was used to assess the level of anxiety and depression; the severity of urinary disorders symptoms was evaluated with the scale of IPSS (International Prostate Symptom Score). To study the sexual dysfunction the international index of erectile dysfunction (ICEF-5) was applied. AMS Men's Age Symptoms (Aging Males Symptoms) questionnaire was used to identify clinical signs of androgen deficiency. The content of testosterone and cortisol in blood serum was determined by EIA. Results and discussion: The growth of androgen deficiency along with the increase in the urinary disorders symptoms, extended anxiety, depression and enhanced signs of erectile dysfunction have been revealed in men with overweight and obesity relating to the men with normal body weight. The androgen deficiency growth influences the aging processes acceleration. In turn, the presence of urological pathology in men can plays an important role in the obesity pathogenesis through the increase in anxiety and depression.

Key words

androgen deficiency, depression, men, obesity, alarm, accelerated aging, erectile dysfunction

References

Celec P., Ostatnikova D., Hodosy J. On the effects of testosterone on brain behavioral functions. Front. Neurosci. 2015. 9. 12.

Dedov I.I., Melnichenko G.A., Rozhivanov R.V., Kurbatov D.G. Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients. Problemy endokrinologii = Problems of endocrinology. 2015. 61. (5). 60-71. [In Russian].

Epanchintseva E.A., Selyatitskaya V.G., Sheina Y.I. Ejaculate parameters in patients with abdominal obesity. Andrologiya i genital'naya khirurgiya = Andrology and Genital Surgery. 2015. 16. (1). 88-93. [In Russian].

Fugh-Berman A., Scialli A.R. Testosterone and sexual function. Curr. Opin. Urol. 2017. 27. (6). 516-518.

Iskanderov B.G. Affective disorders and heart rhythm disturbances. Penza: 2011.168 p. [In Russian].

Ivanchenko D.N., Dorofeeva N.P., Shlyk S.V. Depressive disorders in patients with cardiovascular disease: determining the prognosis. Meditsinskiy vestnik Yuga Rossii = Medical Herald of the South of Russia. 2016. (1).28-32. [In Russian].

Khera M. Patients with testosterone deficiency syndrome and depression. Arch. Esp. Urol. 2013. 66. (7). 729-736.

Kim E.Y., Kim S.H., Ha K., Lee H.J., Yoon D.H., Ahn Y.M. Depression trajectories and the association with metabolic adversities among the middle-aged adults. J. Affect. Disord. 2015. 188. 14-21.

Novikova E., Selyatitskaya V., Mitrofanov I., Pinkhasov B., Karapetyan A. Association of erectile dysfunction and hypogonadism with metabolic syndrome in men with lower urinary tract symptoms of younger and older age groups. Adv. Sex. Med. 2014. 4. 55-64.

Paltsev M.A., Kvetnoy I.M., Polyakova V.O., Kvetnaiya T.V., Trofimov A.V. Neuroimmunoendocrine mechanisms of aging. Adv. Gerontol. 2011. 1. (1). 28–38.

Patent № 2387374 RF. Method for determining the biological age of a person and the rate of aging / Gorelkin A.G., Pinkhasov B.B.; published 27.04.2010. [In Russian].

Penninx B.W.J.H., Milaneschi Y., Lamers F., Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med. 2013. 11. 129.

Shabsigh R., Arver S., Channer K.S., Eardley I., Fabbri A., Gooren L., Heufelder A., Jones H., Meryn S., Zitzmann M. The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int. J. Clin. Pract. 2008. 62. (5). 791-798.

Soboleva N.P., Rudnev S.G., Nikolayev D.V., Eryukova T.A., Kolesnikov V.A., Mel'nichenko O.A., Ponomareva E.G., Starunova O.A., Sterlikov S.A. The bio-impedance screening of population in health centers: prevalence of surplus body mass and obesity. Rossiyskiy meditsinskiy zhurnal = Russian Medical Journal. 2014. (4). 4-13. [In Russian].

Suija K., Kerkela M., Rajala U., Jokelainen J., Laakso M., Harkonen P., Keinanen-Kiukaanniemi S., Timonen M. The association between erectile dysfunction, depressive symptoms and testosterone levels among middle-aged men. Scand. J. Public Health. 2014. 42. (7). 677-682.

Uzbekov M.G., Maksimova N.M. Monoamine-hormonal interactions in the pathogenesis of anxious depression. Zhurnal nevrologii i psikhiatrii imeni Sergeya Sergeevicha Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2015. 1. (2). 52-55. [In Russian].

Westley C.J., Amdur R.L., Irwig M.S. High rates of depression and depressive symptoms among men referred for borderline testosterone levels. J. Sex. Med. 2015. 12. (8). 1753-1760.

Yassin A.A., Nettleship J.E., Salman M., Almehmadi Y. Waist circumference is superior to weight and BMI in predicting sexual symptoms, voiding symptoms and psychosomatic symptoms in men with hypogonadism and erectile dysfunction. Andrologia. 2017.49.(4).e12634.

About Authors (Correspondence):

Selyatitskaya V.G. – doctor of biological sciences, professor, chief researcher of the laboratory of endocrinology, e-mail: ccem@centercem.ru

Full Text

snmzh_1-2018_vasil_eva_i_dr.pdf

Received: 26/02/2018

Accepted: 26/02/2018